Cheaper Drug Prices in US Is About Political Will, Not Economics or Market Forces

  • 📰 commondreams
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Lynn Parramore is Senior Research Analyst at the Institute for New Economic Thinking. She is also a frequent contributor to Reuters, Al Jazeera, Salon, Huffington Post, and other outlets. Her first book of cultural history, Reading the Sphinx (Palgrave Macmillan) was named a 'Notable Scholarly Book for 2008' by the Chronicle of Higher Education.

It’s no secret: Americans are getting fleeced on prescription drugs. We fork over three times more than folks in other countries for the same meds while Big Pharma makes massive profits. Yet President Biden’s modest attempt to address this travesty with a list of 10 drugs up for Medicare price negotiations through the Inflation Reduction Act has the drug industry seething.

Few practices have generated as much controversy and debate in recent years as that of companies inflating their stock prices by repurchasing shares of their own stock from the open market – stock buybacks, as they are called. Lazonick, who has been at the forefront of the debate, has long warned that buybacks come at a significant cost to innovation and long-term growth.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 530. in BE

Belgique Dernières Nouvelles, Belgique Actualités